News | January 07, 2022
Lupin launches Molnulup to treat Covid-19
The drug is priced at Rs 2000 for a course of 40 tablets
The drug is priced at Rs 2000 for a course of 40 tablets
The brand is now available pan-India through their distribution partner
A toll-free helpline to be set up to help doctors and patients
The Subject Expert Committee (SEC), on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) on Monday recommended granting permission to manufacture and market anti-Covid pill molnupiravir for restricted emergency use
The product is expected to be available in a week’s time
DCGI approved the drug based on the review of clinical data
The drug will be marketed under the brand name Molnaflu
_256_384.jpg)
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
Subscribe To Our Newsletter & Stay Updated
